Elizabeth Schackmann

545 total citations
10 papers, 231 citations indexed

About

Elizabeth Schackmann is a scholar working on Genetics, Oncology and Cancer Research. According to data from OpenAlex, Elizabeth Schackmann has authored 10 papers receiving a total of 231 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Genetics, 5 papers in Oncology and 4 papers in Cancer Research. Recurrent topics in Elizabeth Schackmann's work include BRCA gene mutations in cancer (6 papers), Cancer Genomics and Diagnostics (3 papers) and PARP inhibition in cancer therapy (3 papers). Elizabeth Schackmann is often cited by papers focused on BRCA gene mutations in cancer (6 papers), Cancer Genomics and Diagnostics (3 papers) and PARP inhibition in cancer therapy (3 papers). Elizabeth Schackmann collaborates with scholars based in United States, Austria and Hong Kong. Elizabeth Schackmann's co-authors include Allison W. Kurian, Meredith Mills, Sylvia K. Plevritis, James M. Ford, Shaveta Vinayak, Melinda L. Telli, Kristin C. Jensen, Lauren Clarke, Michael Smith and Robert W. Carlson and has published in prestigious journals such as Journal of Clinical Oncology, Neurology and Cancer Research.

In The Last Decade

Elizabeth Schackmann

9 papers receiving 223 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elizabeth Schackmann United States 7 107 104 101 77 34 10 231
Sarah V. Colonna United States 12 81 0.8× 50 0.5× 178 1.8× 79 1.0× 30 0.9× 28 315
Mingxuan Xie China 8 47 0.4× 118 1.1× 52 0.5× 138 1.8× 49 1.4× 10 317
Judith Balmaña Gelpí Spain 4 150 1.4× 98 0.9× 126 1.2× 94 1.2× 46 1.4× 9 256
D. Aldrighetti Italy 8 122 1.1× 181 1.7× 230 2.3× 41 0.5× 56 1.6× 19 326
Bernadette A. M. Heemskerk‐Gerritsen Netherlands 5 223 2.1× 118 1.1× 73 0.7× 52 0.7× 15 0.4× 11 282
Julio E. Abugattas Peru 9 73 0.7× 65 0.6× 185 1.8× 67 0.9× 21 0.6× 22 283
Sue Gerty United Kingdom 7 148 1.4× 223 2.1× 216 2.1× 87 1.1× 54 1.6× 9 396
Sze Yee Phuah Malaysia 5 89 0.8× 25 0.2× 53 0.5× 62 0.8× 45 1.3× 5 175
Molly Sebastian United States 4 169 1.6× 134 1.3× 76 0.8× 54 0.7× 15 0.4× 9 263
Eleni Kakouri Cyprus 9 132 1.2× 70 0.7× 116 1.1× 155 2.0× 28 0.8× 17 355

Countries citing papers authored by Elizabeth Schackmann

Since Specialization
Citations

This map shows the geographic impact of Elizabeth Schackmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elizabeth Schackmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elizabeth Schackmann more than expected).

Fields of papers citing papers by Elizabeth Schackmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elizabeth Schackmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elizabeth Schackmann. The network helps show where Elizabeth Schackmann may publish in the future.

Co-authorship network of co-authors of Elizabeth Schackmann

This figure shows the co-authorship network connecting the top 25 collaborators of Elizabeth Schackmann. A scholar is included among the top collaborators of Elizabeth Schackmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elizabeth Schackmann. Elizabeth Schackmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Schackmann, Elizabeth, et al.. (2020). Near‐peer coaching tool for new senior residents. Medical Education. 54(5). 459–460. 3 indexed citations
2.
Sharma, Akanksha, et al.. (2018). Invasive Mucormycosis in an Immunocompetent Non-Diabetic with Severe Acidosis (P5.086). Neurology. 90(15_supplement).
3.
Afghahi, Anosheh, Kirsten M. Timms, Shaveta Vinayak, et al.. (2017). Tumor BRCA1 Reversion Mutation Arising during Neoadjuvant Platinum-Based Chemotherapy in Triple-Negative Breast Cancer Is Associated with Therapy Resistance. Clinical Cancer Research. 23(13). 3365–3370. 55 indexed citations
4.
Abegglen, Lisa M., Elizabeth Schackmann, Christian N. Paxton, et al.. (2017). C/EBPβ-1 promotes transformation and chemoresistance in Ewing sarcoma cells. Oncotarget. 8(16). 26013–26026. 14 indexed citations
5.
Telli, Melinda L., Kristin C. Jensen, Allison W. Kurian, et al.. (2013). PrECOG 0105: Final efficacy results from a phase II study of gemcitabine (G) and carboplatin (C) plus iniparib (BSI-201) as neoadjuvant therapy for triple-negative (TN) and BRCA1/2 mutation-associated breast cancer.. Journal of Clinical Oncology. 31(15_suppl). 1003–1003. 24 indexed citations
6.
Vinayak, Shaveta, Erich Schwartz, Kristin C. Jensen, et al.. (2013). A clinical trial of lovastatin for modification of biomarkers associated with breast cancer risk. Breast Cancer Research and Treatment. 142(2). 389–398. 29 indexed citations
7.
Kwong, Ava, Benjamin A. Goldstein, Jafi A. Lipson, et al.. (2012). Breast cancer risk factors differ between Asian and white women with BRCA1/2 mutations. Familial Cancer. 11(3). 429–439. 22 indexed citations
8.
Schackmann, Elizabeth, et al.. (2012). Feasibility evaluation of an online tool to guide decisions for BRCA1/2 mutation carriers. Familial Cancer. 12(1). 65–73. 16 indexed citations
9.
Kurian, Allison W., Elizabeth Schackmann, Michael Smith, et al.. (2012). Online Tool to Guide Decisions forBRCA1/2Mutation Carriers. Journal of Clinical Oncology. 30(5). 497–506. 66 indexed citations
10.
Flaherty, Patrick, Irene Wapnir, Bruce L. Daniel, et al.. (2011). P3-14-08: A Phase II Study of Gemcitabine and Carboplatin (GC) Plus Iniparib (BSI-201) as Neoadjuvant Therapy for Triple-Negative and BRCA1/2 Mutation-Associated Breast Cancer.. Cancer Research. 71(24_Supplement). P3–14. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sarah V. Colonna Breakdown of academic impact, for papers by Mingxuan Xie Breakdown of academic impact, for papers by Judith Balmaña Gelpí Breakdown of academic impact, for papers by D. Aldrighetti Breakdown of academic impact, for papers by Bernadette A. M. Heemskerk‐Gerritsen Breakdown of academic impact, for papers by Julio E. Abugattas Breakdown of academic impact, for papers by Sue Gerty Breakdown of academic impact, for papers by Sze Yee Phuah Breakdown of academic impact, for papers by Molly Sebastian Breakdown of academic impact, for papers by Eleni Kakouri
Rankless by CCL
2026